Filter News
Area of Research
- (-) Nuclear Science and Technology (12)
- Advanced Manufacturing (22)
- Biological Systems (1)
- Biology and Environment (52)
- Building Technologies (1)
- Clean Energy (104)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (2)
- Electricity and Smart Grid (1)
- Energy Frontier Research Centers (1)
- Functional Materials for Energy (1)
- Fusion and Fission (7)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (27)
- Materials (100)
- Materials for Computing (16)
- National Security (9)
- Neutron Science (28)
- Quantum information Science (2)
- Supercomputing (71)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (4)
- (-) Biomedical (2)
- (-) Isotopes (5)
- (-) Space Exploration (5)
- Advanced Reactors (11)
- Bioenergy (1)
- Computer Science (2)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (1)
- Fusion (8)
- Materials Science (3)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Physics (2)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.